Literature DB >> 8461929

Familial scleroderma: HLA antigens and autoantibodies.

M Hietarinta1, S Koskimies, O Lassila, E Soppi, A Toivanen.   

Abstract

We report clinical and serological findings as well as the results of extended (HLA-A, B, C, DR and complotype) haplotype determinations of a family with two cases of systemic scleroderma and one case of primary biliary cirrhosis and incomplete CREST syndrome in a sibship of eight. In addition, one of these eight siblings has showed immunological findings of autoimmune disease for years but has not developed clinical symptoms. This family was studied by Soppi et al. in 1982; one member of the family has since then developed primary biliary cirrhosis and incomplete CREST type scleroderma. All family members with scleroderma or related disease as well as their sister with immunological abnormalities share the A2; B8; DR3 haplotype. Also some members of the family share the same haplotype but have remained healthy. This haplotype seems to be a predisposing factor but additional genetic or environmental factors are probably necessary for expression of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8461929     DOI: 10.1093/rheumatology/32.4.336

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  3 in total

1.  An immunogenetic study of familial scleroderma.

Authors:  M D de Juan; J Belzunegui; I Belmonte; J Barado; M Figueroa; J Cancio; S Vidal; E Cuadrado
Journal:  Ann Rheum Dis       Date:  1994-09       Impact factor: 19.103

Review 2.  Induction of tolerance in autoimmune diseases by hematopoietic stem cell transplantation: getting closer to a cure?

Authors:  Richard K Burt; Shimon Slavin; William H Burns; Alberto M Marmont
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.319

Review 3.  Non-myeloablative stem cell transplantation for autoimmune diseases.

Authors:  Richard K Burt; Larissa Verda; Yu Oyama; Laisvyde Statkute; Shimon Slavin
Journal:  Springer Semin Immunopathol       Date:  2004-07-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.